The short version
AMBU BlueSensor and MedLinket V0014 / V0015 are both reputable disposable ECG electrode families that meet the same AAMI EC12, ISO 10993 and ISO 13485 standards, and both use an offset connector design. The differences that matter for procurement are in breadth of sterile packaging (MedLinket offers sterile variants across all six standard sizes), breadth of imaging-compatible options (the full V0015 carbon-snap radiolucent series in six sizes), the specific offset structure (MedLinket's is protected under utility-model patent CN202120112524.5), and pricing positioning (MedLinket typically sits below the AMBU premium tier in many markets). AMBU has decades of installed base — particularly in European hospitals — and a real clinician-familiarity advantage that any switching evaluation should acknowledge. The honest approach for a tender is to evaluate both on documentation, bench testing and total cost of ownership, not on per-unit price alone.
📋 What this guide covers: why hospitals evaluate alternatives to any single supplier; the AMBU BlueSensor family in factual context; a side-by-side comparison of certifications, packaging, sterile and radiolucent options and pricing positioning; the MedLinket offset structural patent; an honest account of what AMBU does well; a 4-step BMET switching-evaluation protocol; and the documentation any switching project should expect from every candidate supplier.
↗️ This is the head-to-head comparison node within our broader 12-criterion ECG electrode supplier evaluation guide. For a brand-compatibility companion see GE compatible disposable electrode pads, and for the lab data behind the offset design see offset vs center-post ECG electrodes.
❌ Not covered here: current AMBU pricing or SKU availability (verify directly with AMBU or authorized distributors), and the technical fundamentals of electrode design (see the complete ECG electrodes guide).
🎯 Best for: procurement managers running a tender that includes both suppliers, BMETs evaluating a switching decision, infection-control teams comparing sterile-packaging availability, and distributors building a multi-supplier portfolio.
Educational & procurement disclaimer. This is a comparison authored by MedLinket — weight that authorship in your evaluation, and treat it as one input alongside the AMBU sales channel, neutral clinical-engineering literature, and your own bench evaluation. Information about AMBU products here is summarized at a general level; verify all current AMBU specifications, certifications, regional availability and pricing directly with AMBU A/S or authorized AMBU distributors before any decision. AMBU and BlueSensor are trademarks of AMBU A/S, used here solely for legitimate comparative purposes with no implied endorsement, partnership or affiliation. This article does not substitute for any product's IFU, your facility's procurement policy, or applicable regional regulations.
Our goal here is not to argue against AMBU — it is a strong, established product family. It is to give a procurement team running a tender a structured framework for the comparison and an honest accounting of where each family fits.
Why hospitals evaluate alternatives to a single supplier
Short answer: hospitals evaluate alternatives to any single-source supplier for four reasons that have nothing to do with the incumbent's quality — cost-of-monitoring pressure, supply-chain diversification, infection-control upgrades, and feature-set requirements. AMBU BlueSensor is a strong, established family; the case for evaluating alternatives is about portfolio management, not product weakness.
1. Cost-of-monitoring pressure
ICU and telemetry units consume disposable electrodes at scale — a 200-bed continuous-monitoring facility can use 100,000+ pieces a year. Small per-unit differences compound across that volume, and premium-tier suppliers tend to hold pricing power where they have installed-base advantage. Hospitals respond by evaluating mid-tier alternatives that meet the same standards at lower per-unit cost.
2. Supply-chain diversification
The 2020–2024 period showed how single-source disposable supply chains fail acutely under pandemic, regulatory or geopolitical pressure. Many procurement teams now keep a primary supplier plus one or two qualified alternates with separate manufacturing geography. Sourcing two suppliers based in different regions creates manufacturing-geography diversification — confirm each supplier's current manufacturing footprint directly as part of due diligence.
3. Infection-control upgrades
Hospitals upgrading continuous-monitoring infection control — particularly for NICU, oncology, immunocompromised and cath-lab populations — may require sterile-packaged ECG electrode variants where standard non-sterile packaging is no longer acceptable. Sterile-variant availability across the full size range varies between suppliers; this is one of the most common triggers for evaluating an alternate.
4. Feature-set requirements (imaging, offset)
Modern workflows increasingly require imaging-compatible (radiolucent carbon-snap) electrodes for cath lab, EP lab, MRI suite and continuous monitoring on imaging-likely patients. The breadth of carbon-snap options across sizes varies between suppliers, so hospitals upgrading their imaging-electrode workflow may evaluate alternatives specifically for radiolucent SKU coverage.
None of these argue that AMBU is a poor choice — they argue that disciplined procurement should evaluate at least two qualified suppliers in any tender, regardless of the incumbent's quality.
The AMBU BlueSensor family in context
Short answer: AMBU A/S, a Danish medical-device company, has produced disposable ECG electrodes for decades. The BlueSensor (and WhiteSensor) range spans general monitoring, resting ECG, long-term and Holter/ambulatory, stress testing, neonatal and sensitive-skin applications, and AMBU's published materials describe a wet-gel, Ag/AgCl, offset-connector design across much of the line. All variants meet AAMI EC12, ISO 10993 and ISO 13485. Confirm the current product line, variants, certifications and specifications directly with AMBU or authorized distributors.
The BlueSensor family is widely stocked in European hospitals and has substantial installed base across clinical applications. The brand is well recognized among clinical-engineering and nursing staff, and the range covers most of the same clinical scenarios as the MedLinket V0014 / V0015 series — bedside monitoring, telemetry, Holter, stress, neonatal and sensitive skin — with regional availability that buyers should verify at the source.
The procurement reality is that the comparison is rarely about whether AMBU's product is good; it is. The comparison is about whether the alternative meets the same standards, fits the same workflows, and produces a meaningful procurement benefit — cost, supply diversification, feature breadth, infection-control upgrade — that justifies the switching effort.
Side-by-side comparison: AMBU vs MedLinket
Short answer: both families meet the same baseline regulatory and quality standards and both use an offset connector. The procurement-relevant differences sit in sterile-packaging breadth, imaging-compatible SKU breadth, the specific (patented) offset structure, and pricing positioning.
⚠️ How to read the table. The AMBU column reflects general, published, industry-level positioning — not a MedLinket measurement of AMBU product. All current AMBU specifications, regional availability and pricing must be verified directly with AMBU A/S or authorized distributors. "Verify with AMBU" marks items to confirm at the source rather than relying on any third-party summary.
| Specification | AMBU BlueSensor (general positioning) | MedLinket V0014 / V0015 offset series |
|---|---|---|
| AAMI EC12 electrical performance | Meets standard verify with AMBU | Meets standard; lot-level test report on request |
| ISO 10993 biocompatibility | Meets standard | Documented; reports on request |
| ISO 13485:2016 quality system | Certified | Certified |
| Connector design | Offset connector (per AMBU materials) | Offset (eccentric); patented structure (below) |
| Conductive gel / backing | Varies by line verify with AMBU | Semi-solid hydrogel; non-woven backing (low-allergy series default) |
| Sterile packaging across full size range | Varies by region & line verify with AMBU | Available across all six standard sizes (-S- variants) |
| Carbon-snap radiolucent variants | Available in specific variants verify with AMBU | Full V0015 series across all six sizes |
| Offset implementation IP | — | Utility-model patent CN202120112524.5 |
| Sealed shelf life | Per AMBU labelling verify with AMBU | 2 years validated |
| Sterile pouch configuration | Per AMBU labelling | 10 pcs per pouch; ISO 11607-1, -2 validated |
| Per-unit pricing positioning | Premium tier in many markets | Typically below the AMBU premium tier in many markets |
| Hospital installed base | Substantial, especially in Europe | 2,000+ hospitals across 110+ countries |
The MedLinket offset structural patent
Short answer: offset connectors as a general concept are used by several manufacturers, including AMBU. What is specific to MedLinket is the structural implementation — protected under utility-model patent CN202120112524.5 (granted by CNIPA). The patent covers the geometric arrangement of the offset snap, the flexible "neck" linking the snap to the adhesive backing, and the spatial relationship between snap and conductive-gel disc that decouples lead-wire force from the gel–skin interface.
The offset structure is a technical differentiator in the V0014 / V0015 series. In MedLinket internal pull-strength bench testing, the offset structure withstood roughly double or more the lead-wire pull force of center-post (concentric) designs across pull angles from 0° to 90° before disconnection (internal test data — see the full angle-resolved dataset and the click-test and sustained-pull experiments in the dedicated offset vs center-post analysis). These are in-vitro bench values, not a clinical fall-off rate, and should be read as such.
For procurement teams, IP protection on a structural design carries two practical implications. First, the specific geometry tested in that bench data is single-source from MedLinket within the patent's jurisdiction — competing offset products may use different geometric arrangements with different performance, which is exactly why "offset" should not be treated as one interchangeable feature. Second, a granted patent signals a deliberate, documented engineering choice rather than a generic commodity feature. The patent is publicly searchable in the CNIPA database under CN202120112524.5, and is one of multiple patents in MedLinket's portfolio across material, structure and design.
⚠️ On the offset comparison. Because AMBU's own materials describe an offset connector too, the meaningful comparison between two offset products is not "offset vs not" — it is the documented mechanical performance of each specific implementation. Ask each supplier for angle-resolved pull-strength bench data and compare like for like.
What AMBU BlueSensor does well — an honest acknowledgement
Short answer: AMBU has decades of installed base — particularly in European hospitals — and a real clinician-familiarity advantage that any honest switching evaluation should acknowledge. Three areas where the incumbent position carries genuine procurement value: nursing familiarity that lowers transition-training cost, EU regulatory and supply-chain depth, and the cumulative validation history a long-tenured product brings to high-acuity workflows.
1. Clinician familiarity
Nursing staff in many hospitals — especially in Europe — have used AMBU BlueSensor throughout their careers. The application technique, packaging format and removal-and-disposal workflow are second nature. A switch introduces transition friction that procurement teams often underestimate: even if the new electrode performs identically on the bench, staff need application re-training, and protocol-deviation rates rise in the first weeks of any change. That is a real cost the switching analysis should account for.
2. EU regulatory and supply-chain depth
As a Denmark-headquartered manufacturer, AMBU brings substantial EU supply-chain depth, regional distribution and EU MDR documentation maturity. For EU-based hospitals, the documentation pathway may be familiar and regional support may be more responsive than for non-EU manufacturers — worth weighting, particularly for time-sensitive replenishment and post-market surveillance reporting.
3. Cumulative validation history
Long-tenured products accumulate validation history — published use cases, studies referencing the product, hospital-specific protocols built around it. That history is a real asset for high-acuity workflows where a documented track record matters, and any alternative needs time to accumulate equivalent history.
The honest implication: AMBU BlueSensor is not a product to argue against — it is an incumbent with real strengths. The case for evaluating an alternative rests on the four procurement reasons above, not on product weakness.
Where MedLinket V0014 / V0015 has specific procurement advantages
Short answer: three advantages drive most MedLinket switching wins — sterile-packaging coverage across all six standard sizes; full carbon-snap radiolucent (V0015) coverage across all six sizes; and pricing positioning below the AMBU premium tier in many markets. Each maps to a specific procurement scenario.
- Sterile-packaging breadth. The V0014 / V0015 series provides sterile-packaged variants (-S- codes) across all six standard sizes — from the smallest round through the adult Holter 70.5 × 55 mm rectangle — at 10 pieces per pouch, validated to ISO 11607-1, -2. This matters most for NICU upgrade projects, oncology / immunocompromised coverage, and cath-lab / EP-lab integration, where a single supplier can cover more sterile scenarios cleanly. See the six-size SKU map and the patient-type selection guide.
- Radiolucent SKU breadth. The V0015 carbon-snap radiolucent series spans all six sizes in sterile and non-sterile packaging, supporting a hybrid metal-snap (V0014) plus carbon-snap (V0015) stocking strategy across the full patient-size range — enabling pre-emptive carbon-snap application on imaging-likely patients of any age. Full context is in the radiolucent electrodes for CT, DR, MRI & cath lab guide. Note that carbon-snap radiolucent electrodes are imaging-friendly per product documentation but are not assigned an "MR Safe" rating — verify MR-conditional use against the IFU.
- Pricing positioning. MedLinket typically sits below the AMBU premium tier in many markets. Actual quoted price depends on negotiated terms, contract volume, region and SKU, so request formal quotations from both suppliers (or authorized distributors) for the specific SKUs and volumes under consideration. The pricing advantage is usually most consequential at high volumes and on multi-year contracts.
Beyond these three, the patented offset structure provides the bench-data-supported pull-strength advantage above, and the combined V0014 + V0015 portfolio lets hospitals consolidate metal-snap and carbon-snap workflows under one supplier. The hydrophilic adhesive-and-gel package — detailed in the low-allergy electrodes design guide — is positioned for long-wear monitoring and sensitive-skin populations (treat "low-allergy" as a design positioning to confirm against the IFU, not a completed clinical claim).
Switching evaluation protocol: four steps for BMET teams
Short answer: a structured switching evaluation typically takes 2–4 weeks across four steps — documentation review, sample bench evaluation, pilot-unit clinical evaluation, and tender finalization. The protocol suits evaluating any disposable ECG electrode supplier, including AMBU BlueSensor against MedLinket V0014 / V0015 or any other candidate.
Documentation review (week 1)
Request from each candidate (including the incumbent, for direct comparison): the ISO 13485:2016 certificate; FDA 510(k) clearance number(s) for the relevant family (verify in the FDA 510(k) database); CE technical-documentation summary for EU markets; NMPA Class II registration for China; a lot-level AAMI EC12 test report (AC impedance, DC offset, bias-current offset, combined offset instability/noise, defibrillation-overload recovery); ISO 10993-1/-5/-10 biocompatibility documentation; ISO 11607-1, -2 sterile-barrier validation for sterile variants; a latex-free declaration; and shelf-life documentation. Documentation gaps in any candidate are an early disqualifier.
Sample bench evaluation (weeks 1–2)
Request representative samples from each candidate covering your highest-volume SKUs. A MedLinket sample pack typically covers adult bedside and Holter sterile variants, an adult cath-lab radiolucent variant, and a neonatal sterile variant if NICU is in scope. The BMET evaluation should include visual inspection of packaging integrity and gel hydration through the liner, snap-fit verification against your installed monitor lead-wire base, a pull-strength bench check (with supplier-provided data as reference), and a sterile-pouch open-and-handle check for any sterile variants.
Pilot-unit clinical evaluation (weeks 2–4)
Apply candidate samples on a single unit (telemetry step-down works well for representative volume) for 1–2 weeks in parallel with the incumbent on a comparable unit. Track nursing application time, ease of application and removal, mid-shift fall-off events, skin-reaction reports and patient comfort. An operational comparison like this does not need IRB review, but does need infection-control sign-off and unit nurse-leadership approval.
Tender finalization (week 4)
Combine documentation, bench and pilot data into the decision. Criteria typically include per-unit cost, delivered cost-of-monitoring (per-unit price plus nursing-labor adjustments), supply-chain reliability, and any infection-control or feature-set advantages. Document the rationale for future review cycles. Where a candidate is approved as primary, plan a full transition with nursing re-training and a 30–60 day side-by-side stocking window to manage any unforeseen workflow issues.
⚠️ What this protocol does not produce. The 2–4 week protocol is procurement diligence, not clinical research — it does not produce a peer-reviewed clinical study or regulatory validation of any supplier's claims. Any specific patient-outcome claim emerging from pilot data should be flagged and discussed with clinical leadership before informing broader policy.
Documentation checklist for any switching project
The minimum documentation pack a procurement team should expect from any candidate disposable ECG electrode supplier — AMBU and MedLinket alike:
- Quality system: ISO 13485:2016 certificate of the manufacturing facility, with current expiry date.
- Regional regulatory clearance: FDA 510(k) clearance number for U.S. tenders (verifiable in the FDA 510(k) database); CE technical-documentation summary for EU tenders; NMPA Class II registration for China; relevant clearances for other markets (MHRA, ANVISA, TGA, PMDA). See the FDA, ISO & CE compliance guide.
- Electrical performance: lot-level AAMI EC12 test report — AC impedance (average and individual max), DC offset voltage, bias-current offset, combined offset instability/internal noise, and defibrillation-overload recovery.
- Biocompatibility: ISO 10993-1 risk assessment, ISO 10993-5 cytotoxicity, ISO 10993-10 sensitization and irritation test reports.
- Sterile packaging (where applicable): ISO 11607-1, -2 sterile-barrier validation report.
- Latex-free declaration: covering all components (snap, backing, adhesive, gel, release liner).
- Shelf-life documentation: validated sealed shelf life, with the methodology (real-time vs accelerated aging) noted.
- Snap-fit compatibility: declared snap diameter (typically 4.0 mm) and compatibility with major monitor brands. See the 4 mm snap guide.
- Sample availability: for in-hospital BMET bench evaluation, with reasonable MOQ and lead time on follow-on production orders.
- Pull-strength bench data for any offset / eccentric connector claim: supplier-provided angle-resolved data, ideally from documented testing.
📦 Running a tender that includes both AMBU BlueSensor and a candidate alternative?
🎁 Request the switching-evaluation sample pack — adult sterile bedside, adult sterile Holter, adult sterile cath-lab radiolucent, and neonatal sterile (if NICU is in scope) — plus the full documentation pack: lot-level AAMI EC12 test report, ISO 10993-1/-5/-10 biocompatibility documentation, ISO 11607 sterile-barrier validation, ISO 13485:2016 certificate, FDA 510(k) clearance number, latex-free declaration, and angle-resolved pull-strength bench data.
📧 Email shopify@medlinket.com with your hospital name, current incumbent, primary application areas (ICU / telemetry / Holter / NICU / cath lab) and required regional certifications.
💬 WhatsApp our sourcing team on +852 6467 3105 for sample MOQ, lead times and the switching-evaluation protocol template.
Frequently asked questions
Is there an alternative to AMBU BlueSensor ECG electrodes?
Yes. Several reputable manufacturers produce disposable ECG electrodes that meet the same AAMI EC12, ISO 10993 and ISO 13485 standards as AMBU BlueSensor and are commonly evaluated for cost, supply-chain diversification or feature-set reasons. The MedLinket V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) low-allergy series is one such alternative — metal-snap and radiolucent carbon-snap variants across the standard size range, in sterile and non-sterile packaging, with a 2-year sealed shelf life. Request samples from any candidate and run a structured BMET bench evaluation before tender finalization.
Why do hospitals look for AMBU BlueSensor alternatives?
For four common reasons: cost-of-monitoring pressure in high-volume continuous monitoring, supply-chain diversification to reduce single-supplier risk, infection-control upgrades that may require sterile-packaged variants, and feature-set requirements such as radiolucent carbon-snap options for cath-lab integration. Procurement teams typically keep a primary supplier plus one or two qualified alternates.
What are the key differences between AMBU BlueSensor and MedLinket offset electrodes?
Both are designed to meet the same AAMI EC12 electrical and ISO 10993 biocompatibility requirements, and both use an offset connector. They differ mainly in sterile-packaging breadth (MedLinket offers sterile variants across the full size range), imaging-compatible breadth (the full six-size carbon-snap radiolucent V0015 series), the specific offset structure (MedLinket's is protected under utility-model patent CN202120112524.5), and pricing positioning (MedLinket typically below the AMBU premium tier in many markets). Verify current AMBU specifications and pricing directly with AMBU or authorized distributors.
Are AMBU BlueSensor and MedLinket electrodes compatible with the same monitors?
Both use the standard 4 mm snap connector that is mechanically compatible with major patient-monitor brands (Philips, GE, Mindray, Nihon Kohden, Dräger and others), so switching between suppliers generally does not require monitor or lead-wire changes. Always confirm the snap diameter against your installed monitor base before bulk ordering, particularly for legacy monitors or pediatric lead wires.
Can I switch from AMBU BlueSensor to MedLinket without a re-validation process?
It depends on your facility's procurement and infection-control protocols. Most hospitals require a structured switching evaluation — a BMET sample bench evaluation, an infection-control review of the sterile-barrier validation, a clinical-engineering compatibility check against installed monitors, and a nursing application-and-removal pilot — typically completed in 2–4 weeks. MedLinket can supply samples plus the lot-level AAMI EC12 report, ISO 13485:2016 certificate, FDA 510(k) clearance number, ISO 11607 sterile-barrier validation and ISO 10993-1/-5/-10 biocompatibility documentation to support it.
Does MedLinket offer sterile packaging across more sizes?
MedLinket V0014 and V0015 include sterile-packaged variants (the -S- codes) across all six standard sizes, validated to ISO 11607-1, -2 at 10 pieces per pouch. AMBU's sterile offerings vary by region and product line, so buyers comparing sterile availability should verify current AMBU sterile SKUs directly with AMBU or authorized distributors. Sterile-packaged electrodes are generally preferred for NICU, immunocompromised, oncology and cath-lab sterile-field workflows.
What is the price difference between AMBU BlueSensor and MedLinket?
Per-unit pricing varies by region, contract volume, distributor and SKU. MedLinket's positioning is generally below the AMBU premium tier in many markets, but actual quoted prices depend on negotiated terms. Request formal quotations from both suppliers (or authorized distributors) for the specific SKUs and volumes under consideration, and complement per-unit pricing with a total-cost-of-ownership view covering nursing labor, fall-off rates and skin-reaction incidence.
Is the offset connector design patented?
MedLinket's eccentric (offset) ECG electrode structural design is protected under utility-model patent CN202120112524.5, granted by CNIPA and publicly searchable in its database. Offset connectors as a general concept are used by several manufacturers, including AMBU; the patent covers MedLinket's specific structural implementation. Hospitals comparing multiple offset products should request supplier-specific pull-strength bench data to compare implementations directly rather than treating "offset" as a generic feature.
Key takeaways
- Both families are reputable and meet the same AAMI EC12, ISO 10993 and ISO 13485 standards — and both use an offset connector.
- The differences that matter for procurement are sterile-packaging breadth, imaging-compatible SKU coverage, the specific (patented) offset structure, and pricing positioning — not baseline compliance.
- AMBU has real strengths in clinician familiarity, EU regulatory and supply-chain depth, and cumulative validation history. Honest switching evaluations should account for these.
- MedLinket advantages include sterile-packaging breadth across all six sizes, the full V0015 carbon-snap radiolucent series, the offset patent CN202120112524.5, and pricing below the AMBU premium tier in many markets.
- The 4-step switching protocol (documentation, bench, pilot, tender) typically takes 2–4 weeks and yields a defensible decision.
- The minimum documentation pack is the same for any supplier — ISO 13485, regional clearance, lot-level AAMI EC12 report, ISO 10993 biocompatibility, ISO 11607 where applicable, latex-free declaration, shelf-life documentation, snap-fit compatibility, and sample availability.
- Verify AMBU specifications, availability and pricing directly with AMBU or authorized distributors — this article is authored by MedLinket and presents general AMBU positioning that requires source verification.
References & standards
Performance & safety standards
- ANSI/AAMI EC12 — Disposable ECG Electrodes: AC impedance, DC offset voltage, bias-current tolerance, defibrillation-overload recovery, combined offset instability / internal noise.
- ISO 10993-1, -5, -10 — Biological evaluation of medical devices: framework, cytotoxicity, sensitization, applicable to electrode adhesives.
- ISO 11607-1, -2 — Packaging for terminally sterilized medical devices: sterile-barrier requirements for sterile variants from any supplier.
- ISO 13485:2016 — medical-device quality-management systems.
Regulatory & IP references
- U.S. FDA 510(k) database — searchable at the FDA 510(k) database; verify any candidate supplier's clearance number directly.
- EU MDR (2017/745) — CE-marking requirements for ECG electrodes sold in the EU, applicable to AMBU, MedLinket and any other supplier.
- NMPA (China) — Class II registrations applicable to MedLinket V0014 / V0015 series.
- CNIPA — China National Intellectual Property Administration patent database, including offset structural-design patent CN202120112524.5.
Supplier verification
- AMBU A/S — manufacturer of the AMBU BlueSensor / WhiteSensor families. AMBU is a trademark of AMBU A/S; current AMBU specifications, regional availability, certifications and pricing must be verified directly with AMBU or authorized distributors via AMBU's website and distributor channels.
- MedLinket (Shenzhen Med-link Electronics Tech Co., Ltd) — manufacturer of the V0014 / V0015 families. Current specifications, certifications and pricing via shopify@medlinket.com and https://med-linket-corp.com.
Internal product references (available on request)
- MedLinket internal product specification documentation — V0014 / V0015 sizes, snap material, backing material (non-woven low-allergy default), packaging formats and 2-year sealed shelf life. Available via shopify@medlinket.com.
- MedLinket internal product training documentation — the comparison framework and switching-evaluation protocol referenced here.
- MedLinket internal pull-strength bench test — angle-resolved pull-force test (0°–90°) comparing center-post and offset connector designs on representative production lots; full report on request.
- Patent CN202120112524.5 — MedLinket eccentric ECG electrode structural design (granted utility-model patent), publicly searchable in the CNIPA database.
Continue reading
Related articles in MedLinket's ECG Electrodes content cluster:
- How to Evaluate ECG Electrode Suppliers: 12 Must-Check Criteria — the broader supplier-evaluation framework this comparison sits within.
- Offset vs Center-Post ECG Electrodes: Lab Data on Edge-Stress Reduction — the angle-resolved pull-strength data behind the offset section.
- GE Compatible Disposable Electrode Pads — the brand-compatibility companion comparison.
- ECG Electrodes: The Complete Buyer's & Clinical Guide (2026) — the parent pillar.
- Low-Allergy ECG Electrodes Explained — the design package that pairs with the offset structure.
- Foam vs Non-Woven ECG Electrodes — backing-material analysis.
- Solid Gel vs Liquid Gel ECG Electrodes — gel-formulation analysis.
- Radiolucent ECG Electrodes for CT, DR, MRI & Cath Lab — the V0015 carbon-snap series context.
- Best ECG Electrodes for Holter Monitoring & Telemetry — the long-wear application context.
- ECG Electrodes by Patient Type — population-by-population selection.
🔧 Procurement, BMET or infection-control questions on a switching evaluation or tender?
📧 Email our clinical engineering team: shopify@medlinket.com · 💬 WhatsApp: +852 6467 3105
Request the switching-evaluation sample pack, full documentation set (lot-level AAMI EC12 report, ISO 13485:2016 certificate, FDA 510(k) clearance number, ISO 11607 sterile-barrier validation, ISO 10993-1/-5/-10 biocompatibility, latex-free declaration), and the bilingual (English/Chinese) switching-evaluation protocol template.
About MedLinket
MedLinket (Shenzhen Med-link Electronics Tech Co., Ltd) has specialised in capturing and transmitting vital biological signals since 2004. The company holds ISO 13485:2016, ISO 9001:2015 and MDSAP certifications alongside NMPA, FDA 510(k) and CE product registrations, and supplies more than 2,000 hospitals across over 110 countries with disposable ECG electrodes, single-patient-use ECG lead wires, SpO₂ sensors, NIBP cuffs, IBP transducers, temperature probes and EtCO₂ accessories.
The MedLinket V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) ECG electrode series span the standard size range through the adult Holter 70.5 × 55 mm size, in sterile and non-sterile packaging, with a validated 2-year sealed shelf life. The eccentric (offset) structural design available within the series is protected under utility-model patent CN202120112524.5 — one of multiple patents in the company's portfolio. Certification documents and the internal test reports referenced here are available on request via shopify@medlinket.com.
